Charles River Laboratories International, Inc. (CRL): Price and Financial Metrics


Charles River Laboratories International, Inc. (CRL): $232.64

0.87 (+0.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CRL POWR Grades


  • Growth is the dimension where CRL ranks best; there it ranks ahead of 86.82% of US stocks.
  • CRL's strongest trending metric is Stability; it's been moving down over the last 179 days.
  • CRL's current lowest rank is in the Momentum metric (where it is better than 41.53% of US stocks).

CRL Stock Summary

  • With a market capitalization of $14,688,915,375, Charles River Laboratories International Inc has a greater market value than 84.86% of US stocks.
  • CRL's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,406.99 -- higher than 97.78% of US-listed equities with positive expected earnings growth.
  • With a year-over-year growth in debt of 36.71%, Charles River Laboratories International Inc's debt growth rate surpasses 80.13% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Charles River Laboratories International Inc are AMEH, BR, G, ENSG, and ENV.
  • Visit CRL's SEC page to see the company's official filings. To visit the company's web site, go to www.criver.com.

CRL Valuation Summary

  • CRL's price/sales ratio is 6.8; this is 40.09% lower than that of the median Healthcare stock.
  • CRL's price/sales ratio has moved up 2.9 over the prior 243 months.
  • Over the past 243 months, CRL's price/sales ratio has gone up 2.9.

Below are key valuation metrics over time for CRL.

Stock Date P/S P/B P/E EV/EBIT
CRL 2021-08-31 6.8 9.6 56.5 42.2
CRL 2021-08-30 6.8 9.7 56.6 42.3
CRL 2021-08-27 6.7 9.5 55.6 41.6
CRL 2021-08-26 6.7 9.5 55.7 41.7
CRL 2021-08-25 6.7 9.4 55.1 41.3
CRL 2021-08-24 6.6 9.3 54.4 40.8

CRL Growth Metrics

    Its 5 year price growth rate is now at 98.15%.
  • Its 3 year revenue growth rate is now at 70.04%.
  • Its 4 year revenue growth rate is now at 94.86%.
CRL's revenue has moved up $2,142,404,000 over the prior 70 months.

The table below shows CRL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 3,540.16 760.799 390.982
2021-09-30 3,426.1 669.92 396.595
2021-06-30 3,273.463 672.498 396.078
2021-03-31 3,041.44 648.214 375.065
2020-12-31 2,923.933 546.575 364.304
2020-09-30 2,824.081 588.873 301.461

CRL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CRL has a Quality Grade of C, ranking ahead of 58.62% of graded US stocks.
  • CRL's asset turnover comes in at 0.564 -- ranking 280th of 561 Business Services stocks.
  • CRTO, OOMA, and SCWX are the stocks whose asset turnover ratios are most correlated with CRL.

The table below shows CRL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-26 0.564 0.379 0.141
2021-03-27 0.559 0.371 0.139
2020-12-26 0.553 0.367 0.135
2020-09-26 0.555 0.367 0.119
2020-06-27 0.558 0.361 0.101
2020-03-28 0.570 0.367 0.096

CRL Price Target

For more insight on analysts targets of CRL, see our CRL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $448.00 Average Broker Recommendation 1.35 (Strong Buy)

CRL Stock Price Chart Interactive Chart >

Price chart for CRL

CRL Price/Volume Stats

Current price $232.64 52-week high $460.21
Prev. close $231.77 52-week low $217.20
Day low $226.08 Volume 368,400
Day high $236.06 Avg. volume 553,651
50-day MA $265.37 Dividend yield N/A
200-day MA $349.41 Market Cap 11.82B

Charles River Laboratories International, Inc. (CRL) Company Bio


Charles River Laboratories provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. The company was founded in 1947 and is based in Wilmington, Massachusetts.


CRL Latest News Stream


Event/Time News Detail
Loading, please wait...

CRL Latest Social Stream


Loading social stream, please wait...

View Full CRL Social Stream

Latest CRL News From Around the Web

Below are the latest news stories about Charles River Laboratories International Inc that investors may wish to consider to help them evaluate CRL as an investment opportunity.

3 Moonshot Stocks Insiders Are Buying. What Do They Know?

Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares.

Thomas Yeung on InvestorPlace | February 25, 2022

Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish

The acquisitions of Cognate BioServices and Vigene Biosciences contribute to the growth of Charles River's (CRL) Manufacturing Solutions arm.

Yahoo | February 22, 2022

Here's Why We Think Charles River Laboratories International (NYSE:CRL) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | February 19, 2022

Analysts Offer Insights on Services Companies: Charles River Labs (CRL), Cheesecake Factory (CAKE) and Trade Desk (TTD)

There's a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Charles River Labs (CRL – Research Report), Cheesecake Factory (CAKE – Research Report) and Trade Desk (TTD – Research Report) with bullish sentiments. Charles River Labs (CRL) In a report released today, Donald Hooker from KeyBanc maintained a Buy rating on Charles River Labs, with a price target of $390.00. The company's shares closed last Wednesday at $305.28. Hooker has an average return of 13.7% and a 52.6% success rate. Patterson covers the Technology sector, focusing on stocks such as NerdWallet, Inc. Class A, Spotify Technology SA, and Alphabet Class A.

Catie Powers on TipRanks | February 17, 2022

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.

Yahoo | February 17, 2022

Read More 'CRL' Stories Here

CRL Price Returns

1-mo -14.79%
3-mo N/A
6-mo -37.12%
1-year -28.91%
3-year 81.13%
5-year 156.72%
YTD -38.26%
2021 50.80%
2020 63.56%
2019 34.97%
2018 3.41%
2017 43.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8281 seconds.